Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer

World Journal of Gastroenterology

Volumn 19, Issue 43, 2013, Pages 7788-7794

  Li, Zhen Jun ^a   Ying, Xiao Jiang ^a   Chen, Hong Liang ^a   Ye, Ping Jiang ^a   Chen, Zhi Liang ^a   Li, Gang ^a   Jiang, Hua Feng ^a   Liu, Jiang ^a   Zhou, Shu Zhen ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Colorectal cancer; Insulin like growth factor 1; Insulin like growth factor 1 receptor; Lymphangiogenesis; Lymphatic metastasis

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION;

COLORECTAL CANCER; INSULIN-LIKE GROWTH FACTOR-1; INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTOR, IGF TYPE 1; UP-REGULATION;

EID: 84888079699     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i43.7788     Document Type: Article

References (35)

1. Cacchi C, Arnholdt HM, Jähnig H, Anthuber M, Probst A, Oruzio DV, Märkl B. Clinical significance of lymph vessel density in T3 colorectal carcinoma. Int J Colorectal Dis 2012; 27: 721-726 [PMID: 22228115 DOI: 10.1007/ s00384-011-1373-7]
2. Gao J, Knutsen A, Arbman G, Carstensen J, Frånlund B, Sun XF. Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig Liver Dis 2009; 41: 116-122 [PMID: 19038587 DOI: 10.1016/j.dld.2008.07.315]
3. Holmqvist A, Gao J, Adell G, Carstensen J, Sun XF. The location of lymphangiogenesis is an independent prognostic factor in rectal cancers with or without preoperative radiotherapy. Ann Oncol 2010; 21: 512-517 [PMID: 19889620 DOI: 10.1093/annonc/mdp486]
4. Yokota J. Tumor progression and metastasis. Carcinogenesis 2000; 21: 497-503 [PMID: 10688870 DOI: 10.1093/carcin/ 21.3.497]
5. Wang TB, Chen ZG, Wei XQ, Wei B, Dong WG. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer. ANZ J Surg 2011; 81: 694-699 [PMID: 22295309 DOI: 10.1111/j.1445-2197]
6. Nagahashi M, Ramachandran S, Rashid OM, Takabe K. Lymphangiogenesis: a new player in cancer progression. World J Gastroenterol 2010; 16: 4003-4012 [PMID: 20731013 DOI: 10.3748/wjg.v16.i32.4003]
7. Fürstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002; 3: 298-302 [PMID: 12067807 DOI: 10.1016/S1470-2045(02)00731-3]
8. Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D. Insulin-like growth factor binding protein-4 and-5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner. Cell Signal 2013; 25: 1395-1402 [PMID: 23499909 DOI: 10.1016/ j.cellsig.2013.02.018]
9. Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, Parnes HL, Tao Y, Figg WD, Lucia MS, Hoque A, Hsing AW, Thompson IM, Pollak M. Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial. Cancer Prev Res (Phila) 2013; 6: 91-99 [PMID: 23315596 DOI: 10.1158/1940-6207.CAPR-12-0250]
10. Baserga R, Peruzzi F, Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer 2003; 107: 873-877 [PMID: 14601044 DOI: 10.1002/ijc.11487]
11. Björndahl M, Cao R, Nissen LJ, Clasper S, Johnson LA, Xue Y, Zhou Z, Jackson D, Hansen AJ, Cao Y. Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci USA 2005; 102: 15593-15598 [PMID: 16230630 DOI: 10.1073/pnas.0507865102]
12. Da MX, Wu Z, Tian HW. Tumor lymphangiogenesis and lymphangiogenic growth factors. Arch Med Res 2008; 39: 365-372 [PMID: 18375246 DOI: 10.1016/j.arcmed.2007.12.005]
13. Yan G, Zhou XY, Cai SJ, Zhang GH, Peng JJ, Du X. Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. World J Gastroenterol 2008; 14: 101-107 [PMID: 18176970 DOI: 10.3748/wjg.14.101]
14. Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumors. 7th ed. Weinheim, Germany: Wiley, 2009
15. Kreisberg JI, Malik SN, Prihoda TJ, Bedolla RG, Troyer DA, Kreisberg S, Ghosh PM. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res 2004; 64: 5232-5236 [PMID: 15289328 DOI: 10.1158/0008-5472.CAN-04-0272]
16. Rinaldi C, Bott LC, Chen KL, Harmison GG, Katsuno M, Sobue G, Pennuto M, Fischbeck KH. Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol Med 2012; 18: 1261-1268 [PMID: 22952056]
17. Murali SG, Brinkman AS, Solverson P, Pun W, Pintar JE, Ney DM. Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and-5 double knockout mice. Am J Physiol Gastrointest Liver Physiol 2012; 302: G794-G804 [PMID: 22281475 DOI: 10.1152/ajpgi. 00372.2011]
18. Zacharakis E, Demetriades H, Pramateftakis MG, Lambrou I, Zacharakis E, Zaraboukas T, Koliakos G, Kanellos I, Betsis D. Effect of IGF-I on healing of colonic anastomoses in rats under 5-FU treatment. J Surg Res 2008; 144: 138-144 [PMID: 17640667 DOI: 10.1016/j.jss.2007.03.045]
19. Zacharakis E, Demetriades H, Kanellos D, Sapidis N, Zacharakis E, Mantzoros I, Kanellos I, Koliakos G, Zaraboukas T, Topouridou K, Betsis D. Contribution of insulin-like growth factor I to the healing of colonic anastomoses in rats. J Invest Surg 2007; 20: 9-14 [PMID: 17365402 DOI: 10.1080/089419306 01126074]
20. Schoppmann SF, Birner P, Stöckl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. Tumorassociated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002; 161: 947-956 [PMID: 12213723 DOI: 10.1016/S0002-9440(10)64255-1]
21. Barresi V, Reggiani-Bonetti L, Di Gregorio C, De Leon MP, Barresi G. Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. J Clin Pathol 2011; 64: 6-12 [PMID: 20947870 DOI: 10.1136/jcp.2010.083550]
22. Yuan Y, Li MD, Hu HG, Dong CX, Chen JQ, Li XF, Li JJ, Shen H. Prognostic and survival analysis of 837 Chinese colorectal cancer patients. World J Gastroenterol 2013; 19: 2650-2659 [PMID: 23674872 DOI: 10.3748/wjg.v19.i17.2650]
23. Lee SR, Kim HO, Son BH, Yoo CH, Shin JH. Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma. Hepatogastroenterology 2013; 60: 358-362 [PMID: 23574658 DOI: 10.5754/hge12727]
24. Hiraga T, Myoui A, Hashimoto N, Sasaki A, Hata K, Morita Y, Yoshikawa H, Rosen CJ, Mundy GR, Yoneda T. Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases. Cancer Res 2012; 72: 4238-4249 [PMID: 22738911 DOI: 10.1158/0008-5472.CAN-11-3061]
25. Huang F, Xu LA, Khambata-Ford S. Correlation between gene expression of IGF-1R pathway markers and cetuximab benefit in metastatic colorectal cancer. Clin Cancer Res 2012; 18: 1156-1166 [PMID: 22294722 DOI: 10.1158/1078-0432. CCR-11-1135]
26. Zhang C, Hao L, Wang L, Xiao Y, Ge H, Zhu Z, Luo Y, Zhang Y, Zhang Y. Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer. BMC Cancer 2010; 10: 184 [PMID: 20459642 DOI: 10.1186/1471-2407-10-184]
27. Hakam A, Yeatman TJ, Lu L, Mora L, Marcet G, Nicosia SV, Karl RC, Coppola D. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum Pathol 1999; 30: 1128-1133 [PMID: 10534157 DOI: 10.1016/ S0046-8177(99)90027-8]
28. Wu Y, Brodt P, Sun H, Mejia W, Novosyadlyy R, Nunez N, Chen X, Mendoza A, Hong SH, Khanna C, Yakar S. Insulinlike growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. Cancer Res 2010; 70: 57-67 [PMID: 20048072 DOI: 10.1158/0008-5472. CAN-09-2472]
29. Lin M, Ma SP, Lin HZ, Ji P, Xie D, Yu JX. Intratumoral as well as peritumoral lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer. Clin Exp Metastasis 2010; 27: 123-132 [PMID: 20195706 DOI: 10.1007/s10585-010-9309-0]
30. Matsumoto K, Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Shibao K, Tsurudome Y, Hirata K, Nagata N, Itoh H. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis Colon Rectum 2007; 50: 308-314 [PMID: 17164964 DOI: 10.1007/s10350-006-0792-y]
31. Stefansson IM, Salvesen HB, Akslen LA. Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res 2006; 66: 3303-3309 [PMID: 16540684 DOI: 10.1158/0008-5472.CAN-05-1163]
32. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005; 201: 1089-1099 [PMID: 15809353 DOI: 10.1084/ jem.20041896]
33. Arcaro A. Targeting the insulin-like growth factor-1 receptor in human cancer. Front Pharmacol 2013; 4: 30 [PMID: 23525758 DOI: 10.3389/fphar.2013.00030]
34. Bruchim I, Werner H. Targeting IGF-1 signaling pathways in gynecologic malignancies. Expert Opin Ther Targets 2013; 17: 307-320 [PMID: 23294364 DOI: 10.1517/14728222.2013.74 9863]
35. Martin JL, Baxter RC. Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3. Growth Factors 2011; 29: 235-244 [PMID: 21895551 DOI: 10.3109/0897719 4.2011.614237]